Company registration number 6382591 (England and Wales)
GRAY HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
GRAY HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
J J Gray
N Berrington
(Appointed 18 April 2024)
Company number
6382591
Registered office
2000 Vortex Court
Enterprise Way
Liverpool
Merseyside
L13 1FB
Auditor
Mitchell Charlesworth (Audit) Limited
Suites C,D,E, & F
14th Floor The Plaza
100 Old Hall Street
Liverpool
L3 9QJ
GRAY HEALTHCARE LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 23
GRAY HEALTHCARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -
The directors present the strategic report for the year ended 31 March 2025.
Review of the business
The business provides home-based rehabilitation and recovery-focused support for adults of working age who have severe and enduring mental health needs, autism spectrum disorder, learning disabilities, or acquired brain injuries. These individuals may also face additional complex healthcare needs that increase their vulnerability.
During the 2024/25 financial year, the company had to adapt its model to ensure profitability amidst significant risks and uncertainties reflective of trends in the broader healthcare sector.
Although the changes led to increased profitability, the focus shifted from growth to realigning business priorities. This included a restructuring of the Executive Leadership team and an emphasis on the quality of interventions and the safety of the individuals being supported. The future proofing of the model has proven to be very successful, providing a solid foundation for growth in 2025/2026 and beyond.
The success of this realignment is supported by a recent Care Quality Commission report. The company was inspected unannounced in May 2025 and received an overall rating of "Good," with an "Outstanding" rating for "Caring." This marks the third consecutive inspection report in which the business has achieved an "Outstanding" rating.
With the Care Quality Commission confirming the effectiveness of the changes, the company is now prepared for growth.
Principal risks and uncertainties
The director has identified several significant risks and uncertainties that the company faces, reflecting trends in the broader healthcare sector. These include compliance with laws and regulations, margin pressure due to sensitivity in contract pricing, and rising employee costs. Particularly noteworthy are the new requirements for all UK employers to implement increased minimum and living wage rates, as well as the rise in employers' National Insurance Contributions (NIC) to 15%.
The director believes that the business is well protected against these principal risks and uncertainties, thanks to its robust internal control processes, strong relationships with local authorities and Integrated Care Boards, and a commitment to high levels of customer service.
Key performance indicators
The key performance indicators during the year were as follows:
31 March 2025
31 March 2024
£'000
£'000
Turnover
10,347
10,298
Gross margin
3,969
3,596
Profit before tax and exceptional items
1,615
898
J J Gray
Director
13 May 2025
GRAY HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
The directors present their annual report and financial statements for the year ended 31 March 2025.
Principal activities
The principal activity of the company during the year was the provision of mental health recovery services.
Results and dividends
The results for the year are set out on page 8.
Ordinary dividends were paid amounting to £186,004. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
J J Gray
N Berrington
(Appointed 18 April 2024)
Disabled persons
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.
Employee involvement
The company's policy is to consult and discuss with employees, through unions, staff councils and at meetings, matters likely to affect employees' interests.
Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.
There is no employee share scheme at present, but the directors are considering the introduction of such a scheme as a means of further encouraging the involvement of employees in the company's performance.
Statement of directors' responsibilities
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
GRAY HEALTHCARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
Strategic report
In accordance with section 414C(11) of the Companies Act 2006 (Strategic Report and Directors’ Report) Regulations 2013 the company’s strategic report information required by schedule 7 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 is noted in the Strategic Report on pages 1 and 2.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
J J Gray
Director
13 May 2025
GRAY HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF GRAY HEALTHCARE LIMITED
- 4 -
Opinion
We have audited the financial statements of Gray Healthcare Limited (the 'company') for the year ended 31 March 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
GRAY HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF GRAY HEALTHCARE LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Extent to which the audit was considered capable of detecting irregularities, including fraud
We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion.
GRAY HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF GRAY HEALTHCARE LIMITED (CONTINUED)
- 6 -
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:
As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas:
(i) The presentation of the profit and loss account, (ii) the company's accounting policy for revenue recognition (iii) the overstatement of salary and other costs In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override.
We also obtained an understanding of the legal and regulatory framework that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the UK Companies Act, FRS102 and the Care Quality Commission.
In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty. These included the registration with the Care Quality Commission, Safeguarding and Data Protection Regulations
GRAY HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF GRAY HEALTHCARE LIMITED (CONTINUED)
- 7 -
Audit response to risks identified
As a result of performing the above, we identified the presentation of the company profit and loss, revenue recognition and overstatement of wages and other costs as the key audit matters related to the potential risk of fraud. The key audit matters section of our report explains the matters in more detail and also describes the specific procedures we performed in response to those key audit matters.
In addition to the above, our procedures to respond to risks identified included the following:
in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.
We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to the member in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member, for our audit work, for this report, or for the opinions we have formed.
Louise Casey
Senior Statutory Auditor
For and on behalf of Mitchell Charlesworth (Audit) Limited
13 May 2025
Accountants
Statutory Auditor
Suites C,D,E, & F
14th Floor The Plaza
100 Old Hall Street
Liverpool
L3 9QJ
GRAY HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2025
2024
Notes
£
£
Turnover
3
10,346,640
10,298,372
Cost of sales
(6,377,267)
(6,702,013)
Gross profit
3,969,373
3,596,359
Administrative expenses
(2,422,742)
(2,699,252)
Operating profit
4
1,546,631
897,107
Interest receivable and similar income
6
74,655
7,945
Interest payable and similar expenses
7
(6,593)
(6,835)
Profit before taxation
1,614,693
898,217
Tax on profit
8
(403,673)
(284,352)
Profit for the financial year
1,211,020
613,865
The profit and loss account has been prepared on the basis that all operations are continuing operations.
GRAY HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
10
74,255
95,682
Current assets
Debtors
11
887,000
1,128,990
Cash at bank and in hand
2,825,881
1,551,651
3,712,881
2,680,641
Creditors: amounts falling due within one year
12
(862,941)
(867,428)
Net current assets
2,849,940
1,813,213
Total assets less current liabilities
2,924,195
1,908,895
Provisions for liabilities
Deferred tax liability
14
6,672
16,388
(6,672)
(16,388)
Net assets
2,917,523
1,892,507
Capital and reserves
Called up share capital
16
500
500
Capital redemption reserve
500
500
Profit and loss reserves
2,916,523
1,891,507
Total equity
2,917,523
1,892,507
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 13 May 2025 and are signed on its behalf by:
J J Gray
Director
Company registration number 6382591 (England and Wales)
GRAY HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 10 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2023
500
500
1,399,646
1,400,646
Year ended 31 March 2024:
Profit and total comprehensive income for the year
-
-
613,865
613,865
Dividends
9
-
-
(122,004)
(122,004)
Balance at 31 March 2024
500
500
1,891,507
1,892,507
Year ended 31 March 2025:
Profit and total comprehensive income for the year
-
-
1,211,020
1,211,020
Dividends
9
-
-
(186,004)
(186,004)
Balance at 31 March 2025
500
500
2,916,523
2,917,523
GRAY HEALTHCARE LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2025
- 11 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
19
1,753,076
814,880
Interest paid
(6,593)
(6,835)
Income taxes paid
(254,976)
(27,133)
Net cash inflow from operating activities
1,491,507
780,912
Investing activities
Purchase of tangible fixed assets
(162,858)
(21,166)
Proceeds from disposal of tangible fixed assets
89,000
5,303
Interest received
74,655
7,945
Net cash generated from/(used in) investing activities
797
(7,918)
Financing activities
Payment of finance leases obligations
(32,070)
(42,759)
Dividends paid
(186,004)
(122,004)
Net cash used in financing activities
(218,074)
(164,763)
Net increase in cash and cash equivalents
1,274,230
608,231
Cash and cash equivalents at beginning of year
1,551,651
943,420
Cash and cash equivalents at end of year
2,825,881
1,551,651
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 12 -
1
Accounting policies
Company information
Gray Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2000 Vortex Court, Enterprise Way, Liverpool, Merseyside, L13 1FB.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of investment properties. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and machinery
3 - 5 years straight line
Fixtures, fittings & equipment
8 years straight line
Motor vehicles and license plate
15 - 25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 13 -
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks and other short-term liquid investments with original maturities of three months or less.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 14 -
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 15 -
Deferred tax
Deferred taxation is provided at appropriate rates on all timing differences using the liability method only to the extent that, in the opinion of the directors, there is a reasonable probability that a liability or asset will crystallise in the foreseeable future.
Provision is not made for tax on unrealised gains arising from the revaluation (and similar fair value adjustments) of investment properties.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.13
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
2
Judgements and key sources of estimation uncertainty
(Continued)
- 16 -
Key sources of estimation uncertainty
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.
Accrued income
Revenue is recognised in the period to which it relates. At year end, where revenue has not been recognised for work completed within the period, an accrued income adjustment is recognised, calculated as being the proportion of the period to which no revenue has been recognised as a proportion of the total period multiplied by the total income receivable.
3
Turnover and other revenue
An analysis of the company's turnover is as follows:
2025
2024
£
£
Turnover analysed by class of business
Sales
10,346,640
10,298,372
2025
2024
£
£
Other revenue
Interest income
74,655
7,945
All turnover was generated within the UK (2024: all)
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
11,400
10,650
Depreciation of owned tangible fixed assets
95,971
130,077
(Profit)/loss on disposal of tangible fixed assets
(686)
3,416
Operating lease charges
34,232
-
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Service delivery
265
257
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
5
Employees
(Continued)
- 17 -
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
6,414,056
6,671,485
Social security costs
578,242
625,710
Pension costs
131,403
171,885
7,123,701
7,469,080
As total directors' remuneration was less than £200,000 in the current year, no disclosure is provided in respect of this.
6
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
74,655
7,945
2025
2024
Investment income includes the following:
£
£
Interest on financial assets not measured at fair value through profit or loss
74,655
7,945
7
Interest payable and similar expenses
2025
2024
£
£
Interest on financial liabilities measured at amortised cost:
Other interest on financial liabilities
6,593
6,835
8
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
413,389
254,976
Adjustments in respect of prior periods
52,363
Total current tax
413,389
307,339
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
8
Taxation
2025
2024
£
£
(Continued)
- 18 -
Deferred tax
Origination and reversal of timing differences
(9,716)
(22,987)
Total tax charge
403,673
284,352
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
1,614,693
898,217
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
403,673
224,554
Tax effect of expenses that are not deductible in determining taxable profit
2,067
Adjustments in respect of prior years
57,731
Taxation charge for the year
403,673
284,352
9
Dividends
2025
2024
£
£
Interim paid
186,004
122,004
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 19 -
10
Tangible fixed assets
Plant and machinery
Fixtures, fittings & equipment
Motor vehicles and license plate
Total
£
£
£
£
Cost
At 1 April 2024
501,025
86,083
587,108
Additions
36,100
3,064
123,694
162,858
Disposals
(108,694)
(108,694)
At 31 March 2025
537,125
89,147
15,000
641,272
Depreciation and impairment
At 1 April 2024
429,389
62,037
491,426
Depreciation charged in the year
65,250
8,091
22,630
95,971
Eliminated in respect of disposals
(20,380)
(20,380)
At 31 March 2025
494,639
70,128
2,250
567,017
Carrying amount
At 31 March 2025
42,486
19,019
12,750
74,255
At 31 March 2024
71,636
24,046
95,682
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 20 -
11
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
635,300
877,099
Other debtors
600
1,000
Prepayments and accrued income
251,100
250,891
887,000
1,128,990
During the year, there was no impairment loss (2024: NIL) recognised against trade debtors.
12
Creditors: amounts falling due within one year
2025
2024
Notes
£
£
Obligations under finance leases
13
32,070
Trade creditors
124,320
124,672
Corporation tax
413,389
254,976
Other taxation and social security
171,529
208,842
Other creditors
31,728
68,927
Accruals and deferred income
121,975
177,941
862,941
867,428
The hire purchase obligations are secured against assets to which the liability relates.
13
Finance lease obligations
2025
2024
Future minimum lease payments due under finance leases:
£
£
Within one year
32,070
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 21 -
14
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
9,576
16,388
Retirement benefit obligations
(2,904)
-
6,672
16,388
2025
Movements in the year:
£
Liability at 1 April 2024
16,388
Credit to profit or loss
(9,716)
Liability at 31 March 2025
6,672
15
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
131,403
161,515
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
16
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
500
500
500
500
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 22 -
17
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2025
2024
£
£
Within one year
126,363
75,353
Between two and five years
116,482
95,969
242,845
171,322
18
Related party transactions
Remuneration of key management personnel
The remuneration of key management personnel is as follows.
2025
2024
£
£
Aggregate compensation
424,404
474,712
The amounts above represent remuneration paid to 6 (2024: 6) employees.
19
Cash generated from operations
2025
2024
£
£
Profit for the year after tax
1,211,020
613,865
Adjustments for:
Taxation charged
403,673
284,352
Finance costs
6,593
6,835
Investment income
(74,655)
(7,945)
(Gain)/loss on disposal of tangible fixed assets
(686)
3,416
Depreciation and impairment of tangible fixed assets
95,971
130,077
Movements in working capital:
Decrease in debtors
241,990
77,269
Decrease in creditors
(130,830)
(292,989)
Cash generated from operations
1,753,076
814,880
GRAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 23 -
20
Analysis of changes in net funds
1 April 2024
Cash flows
31 March 2025
£
£
£
Cash at bank and in hand
1,551,651
1,274,230
2,825,881
Obligations under finance leases
(32,070)
32,070
-
1,519,581
1,306,300
2,825,881
2025-03-312024-04-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300J J GrayN Berrington63825912024-04-012025-03-316382591bus:Director12024-04-012025-03-316382591bus:Director22024-04-012025-03-316382591bus:RegisteredOffice2024-04-012025-03-3163825912025-03-3163825912023-04-012024-03-316382591core:RetainedEarningsAccumulatedLosses2023-04-012024-03-316382591core:RetainedEarningsAccumulatedLosses2024-04-012025-03-3163825912024-03-316382591core:PlantMachinery2025-03-316382591core:FurnitureFittings2025-03-316382591core:MotorVehicles2025-03-316382591core:PlantMachinery2024-03-316382591core:FurnitureFittings2024-03-316382591core:MotorVehicles2024-03-316382591core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-316382591core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-316382591core:CurrentFinancialInstruments2025-03-316382591core:CurrentFinancialInstruments2024-03-316382591core:ShareCapital2025-03-316382591core:ShareCapital2024-03-316382591core:CapitalRedemptionReserve2025-03-316382591core:CapitalRedemptionReserve2024-03-316382591core:RetainedEarningsAccumulatedLosses2025-03-316382591core:RetainedEarningsAccumulatedLosses2024-03-316382591core:ShareCapital2023-03-316382591core:CapitalRedemptionReserve2023-03-316382591core:RetainedEarningsAccumulatedLosses2023-03-316382591core:ShareCapitalOrdinaryShareClass12025-03-316382591core:ShareCapitalOrdinaryShareClass12024-03-3163825912024-03-3163825912023-03-316382591core:PlantMachinery2024-04-012025-03-316382591core:FurnitureFittings2024-04-012025-03-316382591core:MotorVehicles2024-04-012025-03-316382591core:UKTax2024-04-012025-03-316382591core:UKTax2023-04-012024-03-316382591core:PlantMachinery2024-03-316382591core:FurnitureFittings2024-03-316382591core:MotorVehicles2024-03-316382591core:WithinOneYear2025-03-316382591core:WithinOneYear2024-03-316382591bus:OrdinaryShareClass12024-04-012025-03-316382591bus:OrdinaryShareClass12025-03-316382591bus:OrdinaryShareClass12024-03-316382591core:BetweenTwoFiveYears2025-03-316382591core:BetweenTwoFiveYears2024-03-316382591bus:PrivateLimitedCompanyLtd2024-04-012025-03-316382591bus:FRS1022024-04-012025-03-316382591bus:Audited2024-04-012025-03-316382591bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP